Highbridge Capital Management’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-821,157
| Closed | -$62M | – | 441 |
|
|
2026
Q1 | $62M | Buy |
821,157
+209,297
| +34% | +$15.7M | 2.01% | 10 |
|
|
2025
Q4 | $45.6M | Buy |
+611,860
| New | +$44.7M | 1.45% | 17 |
|
|
2019
Q2 | – | Sell |
-137,750
| Closed | -$6.67M | – | 231 |
|
|
2019
Q1 | $6.67M | Sell |
137,750
-122,250
| -47% | -$5.51M | 0.21% | 135 |
|
|
2018
Q4 | $10.7M | Buy |
+260,000
| New | +$10.7M | 0.32% | 96 |
|
|
2018
Q1 | – | Sell |
-5,108
| Closed | -$218K | – | 1401 |
|
|
2017
Q4 | $218K | Sell |
5,108
-45,490
| -90% | -$1.81M | ﹤0.01% | 1446 |
|
|
2017
Q3 | $1.86M | Buy |
50,598
+43,882
| +653% | +$1.77M | 0.03% | 451 |
|
|
2017
Q2 | $305K | Sell |
6,716
-27,423
| -80% | -$1.21M | ﹤0.01% | 957 |
|
|
2017
Q1 | $1.45M | Buy |
+34,139
| New | +$1.39M | 0.02% | 513 |
|
|
2016
Q4 | – | Sell |
-1,025,220
| Closed | -$39.8M | – | 1401 |
|
|
2016
Q3 | $39.8M | Sell |
1,025,220
-284,095
| -22% | -$10.7M | 0.63% | 20 |
|
|
2016
Q2 | $45.3M | Buy |
1,309,315
+805,889
| +160% | +$27.9M | 0.74% | 19 |
|
|
2016
Q1 | $17.4M | Sell |
503,426
-1,924
| -0.4% | -$67.1K | 0.29% | 96 |
|
|
2015
Q4 | $19.6M | Buy |
+505,350
| New | +$19.7M | 0.3% | 95 |
|
|
2015
Q1 | – | Sell |
-59,781
| Closed | -$1.6M | – | 1472 |
|
|
2014
Q4 | $1.6M | Sell |
59,781
-232,189
| -80% | -$5.99M | 0.02% | 525 |
|
|
2014
Q3 | $7.1M | Buy |
+291,970
| New | +$7.37M | 0.09% | 251 |
|
|
2014
Q2 | – | Sell |
-382,564
| Closed | -$8.22M | – | 1163 |
|
|
2014
Q1 | $8.22M | Buy |
+382,564
| New | +$8.25M | 0.1% | 212 |
|
|
2013
Q4 | – | Sell |
-304,899
| Closed | -$6.3M | – | 1170 |
|
|
2013
Q3 | $6.3M | Buy |
304,899
+173,053
| +131% | +$3.68M | 0.07% | 301 |
|
|
2013
Q2 | $2.54M | Buy |
+131,846
| New | +$2.75M | 0.03% | 437 |
|
Other funds holding HOLX
Highbridge Capital Management's HOLX Position: Q2 2026 in Review
Highbridge Capital Management sold out of Hologic (HOLX) in Q2 2026, closing a stake of 821,157 shares — an estimated $62M sold.
Highbridge Capital Management first reported a position in HOLX in Q2 2013 and held it in 17 quarters. The position peaked at $62M in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.
- Highbridge Capital Management reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
- Highbridge Capital Management sold 821,157 Hologic shares in Q2 2026, an estimated $62M.
- Highbridge Capital Management first reported a position in Hologic in Q2 2013 and held it in 17 quarters.
- Highbridge Capital Management's Hologic position peaked at $62M in Q1 2026.
- 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.
Based on Highbridge Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.